Health
Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination – News-Medical.Net
The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain….
A research team led by Dr. Margaret E. Ackerman has observed elevated cross-reactive antibodies to endemic coronaviruses (CoVs), particularly to β-CoV OC43, in severe acute respiratory coronavirus 2 (SARS-CoV-2) natural infection cohorts when compared to…
Continue Reading